LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Home・Stock List・DaVita Inc

DaVita Inc

Closed

SectorHealthcare

114.74 -1.49

Buy Sell

Overview

Share price change

24h

Current

Min

114.45

Max

116.18

Key metrics
By Trading Economics
Income	34M 310M
Sales	41M 3.4B
P/E Sector Avg	12.024 78.892
EPS	2.51
Profit margin	9.051
Employees	76,000
EBITDA	-53M 637M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+18.99% upside

Market Stats
By TradingEconomics
Market Cap	-932M 8.3B
Previous open	116.23
Previous close	114.74

News Sentiment

By Acuity

56%

44%

315 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

142.36 / 144.275 Support & Resistance

DaVita Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Feb 2025, 19:50 UTC

Major Market Movers

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 Mar 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Peer Comparison

Price change

DaVita Inc Forecast

Price Target

By TipRanks

18.99% upside

12 Months Forecast

Average 136.5 USD 18.99%

High 143 USD

Low 130 USD

Based on 4 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to DaVita Inc - Dist in the past 3 months.

Technical Score

By Trading Central

142.36 / 144.275Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

315 / 374 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.